Y. Yao, Z. Qi, Qingqing Zhu, Qi Zhao, Zheng Zhang, S. Fu, Liyao Zhou, Jiaxing Zhu, Zhenhua Liu, Haiyan Xu, Yuhui Huang, J. Xue, S. Qin
{"title":"Erb‐(IL10)2通过激活和募集淋巴结CD8+T细胞诱导放射治疗的脓肿抗肿瘤作用","authors":"Y. Yao, Z. Qi, Qingqing Zhu, Qi Zhao, Zheng Zhang, S. Fu, Liyao Zhou, Jiaxing Zhu, Zhenhua Liu, Haiyan Xu, Yuhui Huang, J. Xue, S. Qin","doi":"10.1002/pro6.1138","DOIUrl":null,"url":null,"abstract":"Although radiotherapy (RT) has been widely used in cancer treatment, it provides limited benefits in patients with metastatic cancers due to rare abscopal antitumor effects. Recent progress in cancer immunotherapy provides a potential new strategy to boost the abscopal antitumor effects of RT.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Erb‐(IL10)2 induces abscopal antitumor effects of radiotherapy through the activation and recruitment of lymph node CD8+ T cells\",\"authors\":\"Y. Yao, Z. Qi, Qingqing Zhu, Qi Zhao, Zheng Zhang, S. Fu, Liyao Zhou, Jiaxing Zhu, Zhenhua Liu, Haiyan Xu, Yuhui Huang, J. Xue, S. Qin\",\"doi\":\"10.1002/pro6.1138\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although radiotherapy (RT) has been widely used in cancer treatment, it provides limited benefits in patients with metastatic cancers due to rare abscopal antitumor effects. Recent progress in cancer immunotherapy provides a potential new strategy to boost the abscopal antitumor effects of RT.\",\"PeriodicalId\":32406,\"journal\":{\"name\":\"Precision Radiation Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Precision Radiation Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/pro6.1138\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Precision Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pro6.1138","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Erb‐(IL10)2 induces abscopal antitumor effects of radiotherapy through the activation and recruitment of lymph node CD8+ T cells
Although radiotherapy (RT) has been widely used in cancer treatment, it provides limited benefits in patients with metastatic cancers due to rare abscopal antitumor effects. Recent progress in cancer immunotherapy provides a potential new strategy to boost the abscopal antitumor effects of RT.